Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: A randomized controlled trial

Respiratory Medicine and Research

Volumn 77, Issue , 2020, Pages 1-7

  Wallaert, B ^a,b   Kyheng, M ^c   Labreuche, J ^c   Stelianides, S ^d   Wemeau, L ^a   Grosbois, J M ^e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c UNIV LILLE   (France)

^d BICHAT HOSPITAL   (France)

^e rue Pietralunga   (France)

Author keywords

Daily life physical activity; Dyspnea; Fatigue; Pulmonary rehabilitation; Sarcoidosis

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DYSPNEA; ENERGY EXPENDITURE; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMAN; LUNG SARCOIDOSIS; MALE; METABOLIC EQUIVALENT; PATIENT COUNSELING; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; BEHAVIOR THERAPY; CLINICAL TRIAL; COMPLICATION; EXERCISE; KINESIOTHERAPY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT-REPORTED OUTCOME; PHYSIOLOGY; PROCEDURES; PSYCHOSOCIAL CARE; RESPIRATORY CARE;

ACTIVITIES OF DAILY LIVING; AGED; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; DYSPNEA; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT REPORTED OUTCOME MEASURES; PHYSICAL CONDITIONING, HUMAN; PSYCHOSOCIAL SUPPORT SYSTEMS; QUALITY OF LIFE; RESPIRATORY THERAPY; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 85076381215     PISSN: None     EISSN: 25900412     Source Type: Journal    
DOI: 10.1016/j.resmer.2019.10.003     Document Type: Article

References (34)

1. Valeyre, D., Bernaudin, J.-F., Jeny, F., et al. Pulmonary Sarcoidosis. Clin Chest Med 36 (2015), 631–641.
2. Baughman, R.P., Teirstein, A.S., Judson, M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (2001), 1885–1889.
3. Bahmer, T., Watz, H., Develaska, M., et al. Physical activity and fatigue in patients with sarcoidosis. Respiration 95 (2018), 18–26.
4. Kostorz, S., Jastrzębski, D., Sikora, M., et al. Predominance of comorbidities in the detriment of daily activity in sarcoidosis patients. Adv Exp Med Biol 1040 (2018), 7–12.
5. Saligan, L.N., The relationship between physical activity, functional performance and fatigue in sarcoidosis. J Clin Nurs 23 (2014), 2376–2379.
6. Froidure, S., Kyheng, M., Grosbois, J., et al. Daily life physical activity in patients with chronic stage IV sarcoidosis: a multicenter cohort study. Health Sci Rep, 2, 2019, e109.
7. Spruit, M.A., Singh, S.J., Garvey, C., et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188 (2013), e13–e64.
8. Strookappe, B., Elfferich, M., Swigris, J., et al. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis Vasc Diffuse Lung Dis 32 (2015), 43–52.
9. McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., Lacasse, Y., Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, 2015, CD003793.
10. Dowman, L., Hill, C.J., Holland, A.E., Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev, 2014, CD006322.
11. Lingner, H., Buhr-Schinner, H., Hummel, S., et al. Short-term effects of a multimodal 3-week inpatient pulmonary rehabilitation programme for patients with sarcoidosis: the ProKaSaRe study. Respiration 95 (2018), 343–353.
12. Naz, I., Ozalevli, S., Ozkan, S., Sahin, H., Efficacy of a structured exercise program for improving functional capacity and quality of life in patients with stage 3 and 4 sarcoidosis: a randomized controlled trial. J Cardiopulm Rehabil Prev 38 (2018), 124–130.
13. Marcellis, R., Van der Veeke, M., Mesters, I., et al. Does physical training reduce fatigue in sarcoidosis?. Sarcoidosis Vasc Diffuse Lung Dis 32 (2015), 53–62.
14. Strookappe, B., Swigris, J., De Vries, J., Elfferich, M., Knevel, T., Drent, M., Benefits of physical training in sarcoidosis. Lung 193 (2015), 701–708.
15. Anon., Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999), 736–755.
16. Grosbois, J.M., Riquier, C., Chehere, B., et al. Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis 11 (2016), 657–663.
17. Mahler, D.A., Wells, C.K., Evaluation of clinical methods for rating dyspnea. Chest 93 (1988), 580–586.
18. De Vries, J., Michielsen, H., Van Heck, G.L., Drent, M., Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 9 (2004), 279–291.
19. Perez, T., Arnould, B., Grosbois, J.-M., et al. Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 4 (2009), 9–18.
20. Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67 (1983), 361–370.
21. Anon., Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993), 1–100.
22. Stocks, J., Quanjer, P.H., Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. Official statement of the European respiratory society. Eur Respir J 8 (1995), 492–506.
23. Pellegrino, R., Viegi, G., Brusasco, V., et al. Interpretative strategies for lung function tests. Eur Respir J 26 (2005), 948–968.
24. Wallaert, B., Talleu, C., Wemeau-Stervinou, L., Duhamel, A., Robin, S., Aguilaniu, B., Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration 82 (2011), 501–508.
25. Hansen, J.E., Sue, D.Y., Wasserman, K., Predicted values for clinical exercise testing. Am Rev Respir Dis 129 (1984), S49–S55.
26. Anon., ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
27. Liang, K.-Y., Zeger, S.L., Longitudinal data analysis of continuous and discrete responses for pre-post designs. Indian J Statistics 62 (2000), 134–148.
28. Liu, G.F., Lu, K., Mogg, R., Mallick, M., Mehrotra, D.V., Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?. Stat Med 28 (2009), 2509–2530.
29. Wallaert, B., Masson, N., Le Rouzic, O., Chéhère, B., Wémeau-Stervinou, L., Grosbois, J.-M., Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients. ERJ Open Res, 4, 2018.
30. Watz, H., Pitta, F., Rochester, C.L., et al. An official European respiratory society statement on physical activity in COPD. Eur Respir J 44 (2014), 1521–1537.
31. Zuwallack, R.L., How do we increase activity and participation in our patients?. Semin Respir Crit Care Med 30 (2009), 708–712.
32. Cindy Ng, L.W., Mackney, J., Jenkins, S., Hill, K., Does exercise training change physical activity in people with COPD?. A systematic review and meta-analysis. Chron Respir Dis 9 (2012), 17–26.
33. Pitta, F., Troosters, T., Probst, V.S., Langer, D., Decramer, M., Gosselink, R., Are patients with COPD more active after pulmonary rehabilitation?. Chest 134 (2008), 273–280.
34. Michielsen, H.J., Drent, M., Peros-Golubicic, T., De Vries, J., Fatigue is associated with quality of life in sarcoidosis patients. Chest 130 (2006), 989–994.